Average Co-Inventor Count = 9.65
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Galapagos Nv (19 from 116 patents)
2. Abbvie S.a.r.l. (14 from 15 patents)
3. Abbvie Inc. (13 from 822 patents)
4. Abbott Laboratories Corporation (9 from 4,177 patents)
5. Abbvie Overseas Sarl (5 from 5 patents)
6. Abbvie Bahamas Limited (6 patents)
7. Abbvie Global Enterprises Ltd. (1 patent)
41 patents:
1. 10988454 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
2. 10981890 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
3. 10954202 - Protein tyrosine phosphatase inhibitors and methods of use thereof
4. 10844042 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
5. 10844041 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
6. 10829473 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
7. 10647717 - N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
8. 10604515 - Heteroaryl substituted pyridines and methods of use
9. 10428017 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
10. 10399940 - Substituted pyrrolidines and methods of use
11. 10259810 - N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
12. 10138227 - Heteroaryl substituted pyridines and methods of use
13. 10130622 - Compounds for treatment of cystic fibrosis
14. 10118916 - Modulators of cystic fibrosis transmembrane conductance regulator protein
15. 10047051 - Substituted pyridines and method of use